Pharmacological treatment of respiratory symptoms

David C. Currow; Amy P. Abernethy

doi:10.1093/acprof:oso/9780199591763.003.0007

Pharmacological treatment of respiratory symptoms

David C. Currow, Amy P. Abernethy

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

This chapter discusses the pharmacological management of breathlessness. Opioids have demonstrated benefit without documented respiratory toxicity. Several psychotropic agents and nebulized furosemide have sufficient promise to warrant rigorous prospective studies. Ultimately, reducing the frightening sensation of breathlessness is something that can be achieved predictably with medications currently available.

Original language	English
Title of host publication	Supportive Care in Respiratory Disease
Editors	Sam H. Ahmedzai, David R. Baldwin, David C. Currow
Publisher	Oxford University Press
Chapter	7
ISBN (Electronic)	9780191739149
ISBN (Print)	9780199591763
DOIs	https://doi.org/10.1093/acprof:oso/9780199591763.003.0007
Publication status	Published - 24 May 2012

Keywords

Breathlessness
Nebulized furosemide
Opioids
Psychotropic agents

Access to Document

10.1093/acprof:oso/9780199591763.003.0007Licence: In Copyright

Cite this

@inbook{8ad51d8bc2d64fc1b9ac90ee07393cec,

title = "Pharmacological treatment of respiratory symptoms",

abstract = "This chapter discusses the pharmacological management of breathlessness. Opioids have demonstrated benefit without documented respiratory toxicity. Several psychotropic agents and nebulized furosemide have sufficient promise to warrant rigorous prospective studies. Ultimately, reducing the frightening sensation of breathlessness is something that can be achieved predictably with medications currently available.",

keywords = "Breathlessness, Nebulized furosemide, Opioids, Psychotropic agents",

author = "Currow, {David C.} and Abernethy, {Amy P.}",

year = "2012",

month = may,

day = "24",

doi = "10.1093/acprof:oso/9780199591763.003.0007",

language = "English",

isbn = "9780199591763",

editor = "Ahmedzai, {Sam H. } and Baldwin, {David R.} and Currow, {David C.}",

booktitle = "Supportive Care in Respiratory Disease",

publisher = "Oxford University Press",

}

TY - CHAP

T1 - Pharmacological treatment of respiratory symptoms

AU - Currow, David C.

AU - Abernethy, Amy P.

PY - 2012/5/24

Y1 - 2012/5/24

N2 - This chapter discusses the pharmacological management of breathlessness. Opioids have demonstrated benefit without documented respiratory toxicity. Several psychotropic agents and nebulized furosemide have sufficient promise to warrant rigorous prospective studies. Ultimately, reducing the frightening sensation of breathlessness is something that can be achieved predictably with medications currently available.

AB - This chapter discusses the pharmacological management of breathlessness. Opioids have demonstrated benefit without documented respiratory toxicity. Several psychotropic agents and nebulized furosemide have sufficient promise to warrant rigorous prospective studies. Ultimately, reducing the frightening sensation of breathlessness is something that can be achieved predictably with medications currently available.

KW - Breathlessness

KW - Nebulized furosemide

KW - Opioids

KW - Psychotropic agents

UR - http://www.scopus.com/inward/record.url?scp=84919663247&partnerID=8YFLogxK

U2 - 10.1093/acprof:oso/9780199591763.003.0007

DO - 10.1093/acprof:oso/9780199591763.003.0007

M3 - Chapter

AN - SCOPUS:84919663247

SN - 9780199591763

BT - Supportive Care in Respiratory Disease

A2 - Ahmedzai, Sam H.

A2 - Baldwin, David R.

A2 - Currow, David C.

PB - Oxford University Press

ER -

Pharmacological treatment of respiratory symptoms

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this